MX2021014674A - Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. - Google Patents

Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.

Info

Publication number
MX2021014674A
MX2021014674A MX2021014674A MX2021014674A MX2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A
Authority
MX
Mexico
Prior art keywords
pyridine
pyrazolo
protein kinase
kinase inhibitors
substituted pyrrolo
Prior art date
Application number
MX2021014674A
Other languages
English (en)
Inventor
Tongshuang Li
Xingdong Zhao
Haohan Tan
Xianlong Wang
Qihong Liu
Zhifu Li
Lihua Jiang
Yanxin Liu
Weibo Wang
Zuwen Zhou
Bin Liu
Weipeng Zhang
Zongyao Zou
Yuwei Gao
Shu Lin
Yunling Wang
Chenglin Zhou
Kai Yu
Original Assignee
Fochon Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fochon Biosciences Ltd filed Critical Fochon Biosciences Ltd
Publication of MX2021014674A publication Critical patent/MX2021014674A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se proporcionan ciertos inhibidores de BTK, sus composiciones farmacéuticas, y métodos de uso de los mismos.
MX2021014674A 2019-05-31 2020-06-01 Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. MX2021014674A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962854983P 2019-05-31 2019-05-31
US201962904611P 2019-09-23 2019-09-23
US201962935091P 2019-11-14 2019-11-14
PCT/CN2020/093734 WO2020239124A1 (en) 2019-05-31 2020-06-01 SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Publications (1)

Publication Number Publication Date
MX2021014674A true MX2021014674A (es) 2022-01-11

Family

ID=73553523

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014674A MX2021014674A (es) 2019-05-31 2020-06-01 Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.

Country Status (10)

Country Link
US (1) US20220235049A1 (es)
EP (1) EP3976607A4 (es)
JP (1) JP2022534715A (es)
KR (1) KR20220016090A (es)
CN (1) CN114008042B (es)
AU (1) AU2020283597A1 (es)
BR (1) BR112021023607A2 (es)
CA (1) CA3137985A1 (es)
MX (1) MX2021014674A (es)
WO (1) WO2020239124A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230110286A (ko) * 2020-11-17 2023-07-21 포천 바이오사이언시스, 리미티드 단백질 키나제 억제제로서 치환된 피롤로 [2,3-b] 피리딘 및 피라졸로 [3,4-b] 피리딘 유도체
EP4234558A1 (en) * 2020-12-07 2023-08-30 Zhejiang Longcharm Bio-Tech Pharma. Co., Ltd. Pyrrolopyridine compound and application thereof
CN112574200B (zh) * 2021-02-26 2021-06-11 安润医药科技（苏州）有限公司 Btk和/或btk的突变体c481s的小分子抑制剂
CN115028633B (zh) * 2021-03-08 2023-12-22 药雅科技(上海)有限公司 吡咯并嘧啶类化合物的制备及其应用
CN113979891A (zh) * 2021-11-08 2022-01-28 上海高准医药有限公司 一种克立硼罗及其中间产物的制备方法
WO2023110970A1 (en) 2021-12-14 2023-06-22 Netherlands Translational Research Center Holding B.V Macrocyclic btk inhibitors
CN114409654A (zh) * 2021-12-30 2022-04-29 安徽普利药业有限公司 一种btk抑制剂的中间体合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1696920E (pt) * 2003-12-19 2015-01-14 Plexxikon Inc Compostos e métodos para o desenvolvimento de moduladores de ret
MY153898A (en) * 2005-06-22 2015-04-15 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
AU2010321883A1 (en) * 2009-11-18 2012-05-31 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
BR112015028845A2 (pt) * 2013-05-30 2017-07-25 Plexxikon Inc compostos para a modulação da quinase e indicações da mesma
WO2018039310A1 (en) * 2016-08-24 2018-03-01 Arqule, Inc. Amino-pyrrolopyrimidinone compounds and methods of use thereof
EP3823968A1 (en) * 2018-07-16 2021-05-26 HepaRegeniX GmbH Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
CN112608318B (zh) * 2019-12-16 2023-09-08 成都海博为药业有限公司 一种作为蛋白质激酶抑制剂的化合物及其用途

Also Published As

Publication number Publication date
EP3976607A1 (en) 2022-04-06
KR20220016090A (ko) 2022-02-08
CN114008042A (zh) 2022-02-01
AU2020283597A1 (en) 2021-11-25
BR112021023607A2 (pt) 2022-01-04
CA3137985A1 (en) 2020-12-03
US20220235049A1 (en) 2022-07-28
EP3976607A4 (en) 2023-07-19
WO2020239124A1 (en) 2020-12-03
CN114008042B (zh) 2023-10-03
JP2022534715A (ja) 2022-08-03

Similar Documents

Publication Publication Date Title
MX2021014674A (es) Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.
IL281127A (en) Pyrazolo[3,4-B]pyridine compounds as inhibitors of TAM and MET kinases
PH12019500776A1 (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
MY196474A (en) [1,2,4]Triazolo[1,5-A]Pyridinyl Substituted Indole Compounds
CL2016002836A1 (es) Compuestos derivados de pirido pirimidin con actividad moduladora del empalme genico de smn2; composicion farmaceutica y uso en el tratamiento de la atrofia muscular espinal (ame).
EP3749293A4 (en) 2,3,4,5-TETRAHYDRO-1H-PYRIDO [4,3-B] INDOLES INHIBITORS OF CGAS USED FOR THE TREATMENT OF SELF-INFLAMMATORY DISEASES
WO2017108723A3 (en) PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
MX2020009586A (es) Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk.
SG11201907095UA (en) DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS
MX2017013874A (es) Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
NZ703111A (en) Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
SG10201807952PA (en) Jak1 inhibitors for the treatment of myelodysplastic syndromes
MX2019007073A (es) Inhibidores de moléculas pequeñas de la familia de quinasas jak.
EP3515914A4 (en) NEW IMIDAZO [1,5-A] PYRIDINES SUBSTITUTED IN POSITION 5 OR 8 AS INDOLEAMINE AND / OR TRYPTOPHANE 2,3-DIOXYGENASES
UY37559A (es) Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
NZ751284A (en) Novel jak1 selective inhibitors and uses thereof
TN2018000078A1 (en) 8-[6-[3-(amino)propoxy]-3-pyridyl]-1 -isopropyl-imidazo[4,5-c]quinolin-2-one derivatives as selective modulators of ataxia telangiectasia mutated (atm) kinase for the treatment of cancer
IL281924A (en) Forms of pyrido[2,1-A]pyrimidin-4-one derivatives, their formulations and process for their preparation
EP4072548A4 (en) COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZINE-1-YL)PYRAZOLO[ 1,5-A]PYRIMIDINE ANALOGUES AS INHIBITORS BY KRAS
MX2018002916A (es) Metodos, composiciones y usos de nuevos inhibidores de fyn quinasa.
MX2019004070A (es) Sistema de extraccion de un sistema de circuito cerrado.
MX2020010116A (es) Compuestos macrociclicos como inhibidores de quinasas del receptor de tropomiosina (trk).
MX2017013886A (es) Azabenzimidazoles y su uso como moduladores del receptor ampa.
PH12019501324A1 (en) Pyrazolo[3,4-b]pyridines and imidazo [1,5-b] pyridazines as pde1 inhibitors